Search results

  1. forestglip

    New Zealand: Dr Matthew Phillips, neurologist

    Thanks for the detailed analysis. Sometimes I think scientists can't be trusted to write their own papers. Should we have a system where some scientists run a study and create data, then they hand it off to people they have no connection to, who analyze it and publish it, somehow with no...
  2. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    Gotcha. Can it just be metabolites related to two different systems? As in the metabolites in plasma that change due to exercise being involved in pathways that are unrelated to the pathways that make urine metabolites increase.
  3. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    Some of the above about how normalization might affect this gets a bit out of my comfort zone, but overall, I think we're basically coming back around to the idea that there may be more variability in deltas in specific metabolites. Exemplified by this amazing illustration: Scenario #1 with...
  4. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    I think I understand, but it seems to me that this is just what we expect to see all the time. I'll refer to this: If one group gets a true effect intervention, while the other gets the placebo, then the plot of change in steps would look pretty similar to the plots from the study. The code...
  5. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    I'm a bit confused about what you're trying to show. HC ends up with a significant difference because they do have a difference, while ME/CFS doesn't because they don't. Your plot has equal SDs for one metabolite, and a true difference between groups, so the plot seems like what we'd expect...
  6. forestglip

    Neuroinflammation: an unfortunate term to describe schizophrenia, 2026, Llorca-Bofí et al

    Maybe that'd be fine in a paper, but in terms of general discussion of a disease, maybe it's good to be able to place it in a category. "What kind of disease are you studying?" "It's neurological. "Oh, interesting, vascular issues? "No, neuroimmune." People outside the field might not have any...
  7. forestglip

    Problems arising for pwME from additional diagnoses of MCAS, hEDS and POTS. Advocacy discussion.

    Would this very brief summary of your thoughts, @Jonathan Edwards, be accurate and maybe clear up some confusion? "If you think you have MCAS or hEDS, and you think telling your doctor might help improve your care, then feel free. If you want to convince others they may have MCAS or hEDS...
  8. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    This part?: This seems to suggest that it's okay to do this: https://repub.github.io/DLC_statistical_guides/docs/R/repeated-measures-ANOVA.html Maybe emmeans accounts for the non-independence if it's a mixed effects model somehow. Whether it's actually good for this, I don't know. Some...
  9. forestglip

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    Oh ok. That's actually reassuring in terms of data privacy if the investigators literally have no way to identify a sample. I assumed the data was anonymized for analysis and for sending to other institutions, but that there would be some sort of master list identifying each sample in a secure...
  10. forestglip

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    If there are any sets of at least two siblings with ME/CFS in the DecodeME cohort, then they could potentially just request the DNA samples of healthy family of those people, since they already have the ME/CFS DNA.
  11. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    My baseline interpretation is, we shouldn't interpret a lack of significance as evidence for a lack of effect. Though what makes me be a bit hesitant to discount on the basis of one group randomly not reaching significance is the stark difference between groups, with hundreds of compounds...
  12. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    Yes, but that's what the delta column is showing. It's not variance of raw values of compounds, it's variance of how much a compound changed before to after exercise. If control compounds tend to trend upward a similar amount, while ME/CFS compounds tend to go up or down in a more spread out...
  13. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    I think they considered whether it might be due to increased variance, and found no general difference in variance between groups. Specifically for changes due to exercise, this would be the Delta plot in S3A below. The plots you posted above might show increased variance in ME/CFS, but this...
  14. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    I think the claim isn't so much meant to be that there is a total lack of change, but that there is a lack of change associated with exercise. For instance, we could imagine some variable that has a huge amount of variability day to day in most people, like step count. If we do an intervention...
  15. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    This quote from Dr. Xu in the webinar seems to say that they did not allow cells to be split up:
  16. forestglip

    Neuroinflammation: an unfortunate term to describe schizophrenia, 2026, Llorca-Bofí et al

    The abstract seems relevant to posts from users like @Jonathan Edwards about the terms "inflammation" and "neuroinflammation" often not being used appropriately in papers.
  17. forestglip

    Neuroinflammation: an unfortunate term to describe schizophrenia, 2026, Llorca-Bofí et al

    Neuroinflammation: an unfortunate term to describe schizophrenia Abstract Schizophrenia, a chronic psychiatric disorder, has prompted extensive research into its immunological aspects. Studies in genetics, epidemiology, and treatment have revealed immune changes associated with schizophrenia...
Back
Top Bottom